Host cell requirements for efficient infection of quiescent primary B lymphocytes by Epstein-Barr virus.
about
Structure and coding content of CST (BART) family RNAs of Epstein-Barr virusControl of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus.Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection.Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cellsEpstein-Barr viruses that express a CD21 antibody provide evidence that gp350's functions extend beyond B-cell surface binding.Molecular genetic analysis of Epstein-Barr virus Cp promoter functionEpstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase.The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infectionEpstein-Barr virus entry.RNAs in Epstein-Barr virions control early steps of infection.Epstein-Barr virus binding to CD21 activates the initial viral promoter via NF-kappaB induction.Use of gHgL for attachment of Epstein-Barr virus to epithelial cells compromises infection.EBV Persistence--Introducing the Virus.Roles of cell signaling pathways in cell-to-cell contact-mediated Epstein-Barr virus transmission.Phosphatidylinositol-dependent membrane fusion induced by a putative fusogenic sequence of Ebola virus.Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.Tracking EBV-encoded RNAs (EBERs) from the nucleus to the excreted exosomes of B-lymphocytes
P2860
Q24524755-25382850-E2C0-499C-888C-AEF9634BCE64Q33813615-D4A1DB3B-7645-4DF8-863C-8E7389E1AC30Q33851043-4CE2A772-02B4-4978-980B-45A6361BC9C3Q34598541-63561196-0702-4F7E-80EB-DFF08B707909Q34613494-2167A190-A280-43BF-8A9E-95EB879C0E8AQ35856784-AFC01435-E775-4859-8B9C-EF028D6DEE3DQ35887119-32AF09B1-93A7-4187-9293-2D62630D20E1Q35887796-AFA5CF2D-9F45-456A-BE4E-F264FD3F2952Q35947541-50ADE86B-A3AA-41AB-9655-C958F0B040E6Q35991530-CBA9BA93-389C-479D-9583-0C10EF0E9B0EQ36380484-7352A47E-403E-4140-99B2-2CDF72219881Q37730214-A4D67D5E-A948-4A1D-947F-0D9AF574FBA3Q38596344-031ADE19-F672-4EE9-8847-5A62C4AD91DCQ39327673-A6DC2DF8-97B3-486C-AE0B-39BFBCE1599DQ39577621-FBFFA3A8-9AA7-4D1E-B8DD-D1A064EAE5E4Q40213284-C17391B7-5CA6-4481-A5BD-628A822F0A28Q58603459-2663B692-A304-497F-B337-EE85F24E9F63
P2860
Host cell requirements for efficient infection of quiescent primary B lymphocytes by Epstein-Barr virus.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Host cell requirements for eff ...... hocytes by Epstein-Barr virus.
@en
Host cell requirements for eff ...... hocytes by Epstein-Barr virus.
@nl
type
label
Host cell requirements for eff ...... hocytes by Epstein-Barr virus.
@en
Host cell requirements for eff ...... hocytes by Epstein-Barr virus.
@nl
prefLabel
Host cell requirements for eff ...... hocytes by Epstein-Barr virus.
@en
Host cell requirements for eff ...... hocytes by Epstein-Barr virus.
@nl
P2860
P1433
P1476
Host cell requirements for eff ...... phocytes by Epstein-Barr virus
@en
P2093
Sinclair AJ
P2860
P304
P407
P577
1995-09-01T00:00:00Z